# Study of NMS-03305293 in Adult Patients With Relapsed Ovarian Cancer

> **NCT06930755** · PHASE1 · RECRUITING · sponsor: **Nerviano Medical Sciences** · enrollment: 24 (estimated)

## Conditions studied

- Ovarian Cancer

## Interventions

- **DRUG:** NMS-03305293
- **DRUG:** Topotecan

## Key facts

- **NCT ID:** NCT06930755
- **Lead sponsor:** Nerviano Medical Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-30
- **Primary completion:** 2027-05-31
- **Final completion:** 2027-09-26
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06930755

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06930755, "Study of NMS-03305293 in Adult Patients With Relapsed Ovarian Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06930755. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*